2606004347
  • Open Access
  • Article

Breath-Based SERS Detection of Propofol Metabolites during Anesthesia Using Mesoporous Au Foam Chips

  • Hui Zhang 1,   
  • Guanghui An 2,   
  • Enduo Feng 1,*

Received: 26 May 2026 | Revised: 16 Jun 2026 | Accepted: 22 Jun 2026 | Published: 24 Jun 2026

Abstract

Propofol anesthesia is commonly guided by hemodynamic signs, infusion parameters, and electroencephalography-derived indices, yet noninvasive molecular approaches for distinguishing anesthesia-related states remain limited. Here, we developed a mesoporous Au foam-based surface-enhanced Raman spectroscopy (SERS) chip for breath analysis of propofol metabolites signatures and anesthesia-state discrimination. The Au foam was fabricated by selective dealloying of Au-Ag alloy films, producing an interconnected ligament-pore architecture with a pore size of 55 nm and ligament width of 24 nm, which showed broad optical extinction near 785 nm, and strong SERS activity with an enhancement factor of approximately 6.84 × 105, as well as spatially uniform mapping over 30 × 30 μm2, batch-to-batch reproducibility, humidity tolerance, 30-day storage stability, and resistance to breath-like gas flow. Using propofol, 4-hydroxypropofol, propofol glucuronide, and propofol sulfate as representative targets, molecule-specific SERS fingerprints and marker peaks were identified, enabling excellent discrimination of these structurally related molecules with classification accuracy above 85% with multivariate analysis. Quantitatively, all of these selected marker peaks showed linear responses over 2–75 ppb, with detection limits down to 0.663 ppb and spike recoveries above 90% in artificial breath matrix. Finally, breath SERS fingerprints collected from awake/pre-anesthesia, propofol anesthesia, and recovery states were analyzed by spectral scoring, PCA, supervised classification, and anesthesia-probability output, which achieved an overall state-discrimination accuracy of 86.7%, demonstrating the potential of mesoporous Au foam SERS chips for noninvasive molecular assessment of propofol anesthesia-related breath states. This work offered a compact optical strategy for molecularly informed assessment of propofol anesthesia-related breath signatures.

Graphical Abstract

References 

  • 1.

    Sahinovic, M.M.; Struys, M.M.R.F.; Absalom, A.R. Clinical Pharmacokinetics and Pharmacodynamics of Propofol. Clin. Pharmacokinet. 2018, 57, 1539–1558.

  • 2.

    Eleveld, D.J.; Colin, P.; Absalom, A.R.; Stuys, M.M.R.F. Pharmacokinetic-Pharmacodynamic Model for Propofol for Broad Application in Anaesthesia and Sedation. Br. J. Anaesth. 2018, 120, 942–959.

  • 3.

    Rosow, C.; Manberg, P.J. Bispectral Index Monitoring. Anesthesiol. Clin. N. Am. 2001, 19, 947–966.

  • 4.

    Miekisch, W.; Schubert, J.K.; Noeldge-Schomburg, G.F.E. Diagnostic Potential of Breath Analysis-Focus on Volatile Organic Compounds. Clin. Chim. Acta. 2004, 347, 25–39.

  • 5.

    Amann, A.; Miekisch, W.; Schubert, J.; Buszewski, B.; Ligor, T.; Jezierski, T.; Pleil, Risby, J.T. Analysis of Exhaled Breath for Disease Detection. Annu. Rev. Anal. Chem. 2014, 7, 455–482.

  • 6.

    Harrison, G.R.; Critchley, A.D.J.; Mayhew, C.A.; Thompson, J.M. Real-Time Breath Monitoring of Propofol and Its Volatile Metabolites during Surgery Using a Novel Mass Spectrometric Technique: A Feasibility Study. Br. J. Anaesth. 2003, 91, 797–799.

  • 7.

    Takita, A.; Masui, K.; Kazama, T. On-Line Monitoring of End-Tidal Propofol Concentration in Anesthetized Patients. Anesthesiology 2007, 106, 659–664.

  • 8.

    Perl, T.; Carstens, E.; Hirn, A.; Quintel, M.; Vautz, W.; Nolte, J.; Jünger, M. Determination of Serum Propofol Concentrations by Breath Analysis Using Ion Molecule Reaction Mass Spectrometry. Br. J. Anaesth. 2009, 103, 822–827.

  • 9.

    Jiang, D.; Li, E.; Zhou, Q.; Wang, X.; Li, H.; Ju, B.; Guo, L.; Liu, D.; Li, H. Online Monitoring of Intraoperative Exhaled Propofol by Acetone-Assisted Negative Photoionization Ion Mobility Spectrometry Coupled with Time-Resolved Purge Introduction. Anal. Chem. 2018, 90, 5280–5289.

  • 10.

    Li, X.; Chang, P.; Zhang, W. Online Monitoring of Propofol Concentrations in Exhaled Breath. Heliyon 2024, 10, e39704.

  • 11.

    Zeng, J.; Stankovic, N.; Singh, K.D.; Steiner, R.; Frey, U.; Erb, T.; Sinues, P. Breath Analysis of Propofol and Associated Metabolic Signatures: A Pilot Study Using Secondary Electrospray Ionization High-Resolution Mass Spectrometry. Anesthesiology 2025, 143, 345–356.

  • 12.

    Meidert, A.S.; Rucz, P.; Angster, J.; Esser, J.; Miklos, A.; Schelling, G. Photoacoustic Detection of Propofol in Breath Gas for Monitoring Depth of Anaesthesia: From Bench to Bedside. Br. J. Anaesth. 2025, 135, 1203–1211.

  • 13.

    Fernández-Lodeiro, A.; Constantinou, M.; Panteli, C.; Agapiou, A.; Andreou, C. Breath Analysis via Surface Enhanced Raman Spectroscopy. ACS Sens. 2025, 10, 602–621.

  • 14.

    Ding, S.Y.; You, E.M.; Tian, Z.Q.; Moskovits, M. Electromagnetic Theories of Surface-Enhanced Raman Spectroscopy. Chem. Soc. Rev. 2017, 46, 4042–4076.

  • 15.

    Pilot, R.; Signorini, R.; Durante, C.; Orian, L.; Bhamidipati, M.; Fabris, L. A Review on Surface-Enhanced Raman Scattering. Biosensors 2019, 9, 57.

  • 16.

    Yi, J.; You, E.M.; Hu, R.; Wu, D.Y.; Liu, G.K.; Yang, Z.L.; Zhang, H.; Gu, Y.; Wang, Y.H.; Wang, X.; et al. Surface-Enhanced Raman Spectroscopy: A Half-Century Historical Perspective. Chem. Soc. Rev. 2025, 54, 3423–3480.

  • 17.

    Zhou, Y.; Gu, Q.Y.; Qiu, T.Z.; He, X.; Chen, J.Q.; Qi, R.J.; Huang, R.; Zheng, T.T.; Tian, Y. Ultrasensitive Sensing of Volatile Organic Compounds Using a Cu-Doped SnO2-NiO p-n Heterostructure That Shows Significant Raman Enhancement. Angew. Chem. Int. Ed. 2021, 60, 26260–26267.

  • 18.

    Wittstock, G.; Bäumer, M.; Dononelli, W.; Klüner, T.; Lührs, L.; Mahr, C.; Moskaleva, L.V.; Oezaslan, M.; Risse, T.; Rosenauer, A.; et al. Nanoporous Gold: From Structure Evolution to Functional Properties in Catalysis and Electrochemistry. Chem. Rev. 2023, 123, 6716–6792.

  • 19.

    Ding, Y.; Kim, Y.J.; Erlebacher, J. Nanoporous Gold Leaf: “Ancient Technology”/Advanced Material. Adv. Mater. 2004, 16, 1897–1900.

  • 20.

    Erlebacher, J.; Aziz, M.J.; Karma, A.; Dimitrov, N.; Sieradzki, K. Evolution of Nanoporosity in Dealloying. Nature 2001, 410, 450–453.

  • 21.

    Qian, L.H.; Yan, X.Q.; Fujita, T.; Inoue, A.; Chen, M.W. Surface Enhanced Raman Scattering of Nanoporous Gold: Smaller Pore Sizes Stronger Enhancements. Appl. Phys. Lett. 2007, 90, 153120.

  • 22.

    Lang, X.Y.; Guan, P.F.; Zhang, L.; Fujita, T.; Chen, M.W. Characteristic Length and Temperature Dependence of Surface Enhanced Raman Scattering of Nanoporous Gold. J. Phys. Chem. C 2009, 113, 10956–10961.

  • 23.

    Lang, X.Y.; Chen, L.Y.; Guan, P.F.; Fujita, T.; Chen, M.W. Geometric Effect on Surface Enhanced Raman Scattering of Nanoporous Gold: Improving Raman Scattering by Tailoring Ligament and Nanopore Ratios. Appl. Phys. Lett. 2009, 94, 213109.

  • 24.

    Li, F.; Luo, S.; Qu, F.; Wang, D.; Li, C.; Liu, X. Electrochemical Dealloying Preparation and Morphology Evolution of Nanoporous Au with Enhanced SERS Activity. Coatings 2023, 13, 489.

  • 25.

    Harmsen, S.; Huang, R.; Wall, M.A.; Karabeber, H.; Samii, J.M.; Spaliviero, M.; White, J.R.; Monette, S.; O’Connor, R.; Pitter, K.L.; et al. Surface-Enhanced Resonance Raman Scattering Nanostars for High-Precision Cancer Imaging. Sci. Transl. Med. 2015, 7, 271ra7.

  • 26.

    Yamakoshi, H.; Dodo, K.; Okada, M.; Ando, J.; Palonpon, A.; Fujita, K.; Kawata, S.; Sodeoka, M. Imaging of EdU, an Alkyne-Tagged Cell Proliferation Probe, by Raman Microscopy. J. Am. Chem. Soc. 2011, 133, 6102–6105.

  • 27.

    Court, M.H.; Duan, S.X.; von Moltke, L.L.; Greenblatt, D.J.; Patten, C.J.; Miners, J.O.; Mackenzie, P.I. Interindividual Variability in Acetaminophen Glucuronidation by Human Liver Microsomes: Identification of Relevant Acetaminophen UDP-Glucuronosyltransferase Isoforms. J. Pharmacol. Exp. Ther. 2001, 299, 998–1006.

  • 28.

    Favetta, P.; Degoute, C.S.; Perdrix, J.P.; Dufresne, C.; Boulieu, R.; Guitton, J. Propofol Metabolites in Man Following Propofol Induction and Maintenance. Br. J. Anaesth. 2002, 88, 653–658.

  • 29.

    Lussier, F.; Thibault, V.; Charron, B.; Wallace, G.Q.; Masson, J.F. Deep Learning and Artificial Intelligence Methods for Raman and Surface-Enhanced Raman Scattering. TrAC Trends Anal. Chem. 2020, 124, 115796.

  • 30.

    Ryzhikova, E.; Kazakov, O.; Halamkova, L.; Celmins, D.; Malone, P.; Molho, E.; Zimmerman, E.A.; Lednev, I.K. Raman Spectroscopy of Blood Serum for Alzheimer’s Disease Diagnostics: Specificity Relative to Other Types of Dementia. J. Biophotonics. 2015, 8, 584–596.

Share this article:
How to Cite
Zhang, H.; An, G.; Feng, E. Breath-Based SERS Detection of Propofol Metabolites during Anesthesia Using Mesoporous Au Foam Chips. Materials and Interfaces 2026, 3 (2), 196–209. https://doi.org/10.53941/mi.2026.100013.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.